SG Americas Securities
BNTX icon

SG Americas Securities’s BioNTech BNTX Stock Holding History

SG Americas Securities’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.3M Buy
347,131
+76,886
+28% +$7.24M 0.02% 461
2026
Q1 		$24M Sell
270,245
-95,088
-26% -$9.77M 0.03% 477
2025
Q4 		$34.8M Buy
365,333
+344,630
+1,665% +$34.7M 0.04% 316
2025
Q3 		$2.04M Sell
20,703
-69,726
-77% -$7.46M 0.01% 940
2025
Q2 		$9.63M Buy
90,429
+51,792
+134% +$5.23M 0.04% 308
2025
Q1 		$3.52M Sell
38,637
-2,833
-7% -$317K 0.01% 589
2024
Q4 		$4.73M Buy
41,470
+33,375
+412% +$3.81M 0.02% 364
2024
Q3 		$961K Sell
8,095
-51,967
-87% -$4.78M ﹤0.01% 1112
2024
Q2 		$4.83M Sell
60,062
-10,081
-14% -$921K 0.03% 557
2024
Q1 		$6.47M Buy
70,143
+60,270
+610% +$5.78M 0.03% 470
2023
Q4 		$1.04M Sell
9,873
-21,367
-68% -$2.15M 0.01% 1001
2023
Q3 		$3.39M Sell
31,240
-9,159
-23% -$1.01M 0.04% 452
2023
Q2 		$4.36M Sell
40,399
-41,413
-51% -$4.66M 0.03% 420
2023
Q1 		$10.2M Buy
81,812
+61,747
+308% +$8.48M 0.12% 130
2022
Q4 		$3.01M Sell
20,065
-45,734
-70% -$7.04M 0.04% 411
2022
Q3 		$8.88M Sell
65,799
-26,570
-29% -$4.06M 0.11% 162
2022
Q2 		$13.8M Sell
92,369
-64,901
-41% -$9.92M 0.15% 109
2022
Q1 		$26.8M Sell
157,270
-19,152
-11% -$3.22M 0.2% 80
2021
Q4 		$45.5M Buy
176,422
+34,781
+25% +$9.53M 0.25% 57
2021
Q3 		$38.7M Sell
141,641
-12,066
-8% -$3.83M 0.18% 68
2021
Q2 		$34.4M Sell
153,707
-12,501
-8% -$2.36M 0.16% 111
2021
Q1 		$18.1M Sell
166,208
-6,490
-4% -$689K 0.1% 190
2020
Q4 		$14.1M Buy
172,698
+83,821
+94% +$8.23M 0.08% 200
2020
Q3 		$6.15M Buy
88,877
+53,196
+149% +$3.82M 0.04% 285
2020
Q2 		$2.38M Buy
35,681
+32,372
+978% +$1.62M 0.02% 720
2020
Q1 		$193K Buy
+3,309
New +$129K ﹤0.01% 2527

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

SG Americas Securities's BNTX Position: Q2 2026 in Review

SG Americas Securities increased its BioNTech (BNTX) stake by 28% in Q2 2026, buying an estimated $7.24M and bringing the position to 347,131 shares worth $32.3M. The position accounts for 0.02% of the portfolio, ranked #461.

SG Americas Securities first reported a position in BNTX in Q1 2020 and has held it in 26 quarters since. The position peaked at $45.5M in Q4 2021. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • SG Americas Securities held 347,131 shares of BioNTech worth $32.3M as of Q2 2026.
  • SG Americas Securities bought 76,886 BioNTech shares in Q2 2026, an estimated $7.24M.
  • BioNTech made up 0.02% of SG Americas Securities's portfolio in Q2 2026, its #461 holding.
  • SG Americas Securities first reported a position in BioNTech in Q1 2020 and has held it in 26 quarters since.
  • SG Americas Securities's BioNTech position peaked at $45.5M in Q4 2021.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.